These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38473773)

  • 1. Mesoporous Silicon Nanoparticles with Liver-Targeting and pH-Response-Release Function Are Used for Targeted Drug Delivery in Liver Cancer Treatment.
    Wei J; Tan Y; Bai Y; He J; Cao H; Guo J; Su Z
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
    J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-cloaked polydopamine modified mesoporous silica nanoparticles for cancer therapy.
    Wang Z; Shi J; Pan H; Liu M; Sang Y; Ai J; Liu Y; Chen L
    Nanotechnology; 2022 Jun; 33(34):. PubMed ID: 35576909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.
    Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X
    Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
    Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of Polydopamine-Coated Mesoporous Silica Nanorods and Spheres for the Delivery of Hydrophilic and Hydrophobic Anticancer Drugs.
    Pada AK; Desai D; Sun K; Prakirth Govardhanam N; Törnquist K; Zhang J; Rosenholm JM
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Evaluation of pH Responsive Doxazosin Loaded Mesoporous Silica Nanoparticles: A Smart Approach in Drug Delivery.
    Guha A; Biswas N; Bhattacharjee K; Das P; Kuotsu K
    Curr Drug Deliv; 2016; 13(4):574-81. PubMed ID: 26201344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the anti-cancer activity of a mesoporous silica nanoparticle surface coated with polydopamine loaded with umbelliprenin.
    Edalatian Tavakoli S; Motavalizadehkakhky A; Homayouni Tabrizi M; Mehrzad J; Zhiani R
    Sci Rep; 2024 May; 14(1):11450. PubMed ID: 38769394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
    Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
    Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-Responsive Mesoporous Silica Nanoparticles with Synergistic Anti-inflammatory and Joint Protection Effects for Rheumatoid Arthritis Treatment.
    Wu YZ; Chen WY; Zeng Y; Ji QL; Yang Y; Guo XL; Wang X
    Pharm Res; 2024 Jul; 41(7):1493-1505. PubMed ID: 38918308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-Functionalized Mesoporous Silica Nanoparticles for Celecoxib Delivery: Amine Grafting and Imidazolyl PEI Gatekeepers for Enhanced Loading and Controlled Release with Reduced Toxicity.
    Mudhakir D; Sadaqa E; Permana Z; Mumtazah JE; Zefrina NF; Xeliem JN; Hanum LF; Kurniati NF
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39124951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized mesoporous silica nanoparticle-based drug delivery system with removable manganese oxide gatekeeper for controlled delivery of doxorubicin.
    Miao Y; Feng Y; Bai J; Liu Z; Zhao X
    J Colloid Interface Sci; 2021 Jun; 592():227-236. PubMed ID: 33662827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.
    Wei Y; Gao L; Wang L; Shi L; Wei E; Zhou B; Zhou L; Ge B
    Drug Deliv; 2017 Nov; 24(1):681-691. PubMed ID: 28414557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordination bonding-based polydopamine-modified mesoporous silica for sustained avermectin release.
    Shen Z; Wen H; Zhou H; Hao L; Chen H; Zhou X
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110073. PubMed ID: 31546444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
    Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
    Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
    Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
    Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvianolic acid B-loaded polydopamine-modified hollow mesoporous organic silica nanoparticles for treatment of breast cancer metastasis via suppressing cancer-associated fibroblasts.
    Hu M; Cheng N; Wang S; Li R; Liu Y; Wang L; Chen W; Chen Y
    Eur J Pharm Sci; 2024 Jan; 192():106641. PubMed ID: 37972905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.